Ensilitech
3 known investors
EnsiliTech develops ensilication technology, a silica-based method to stabilise vaccines and biopharmaceuticals so they can be stored and transported without refrigeration. The company serves the pharmaceutical and biotech industry and originated from research at the University of Bath.
Founders & leadership
AS
Asel SartbaevaCo-Founder & CEO
MS
Matt SladeCo-Founder & Chief of Staff
SW
Stephen WellsCo-Founder & Advisor
AD
Aswin DoekhieCo-Founder & CTO
SF
Sabine FicekCFO
SB
Simon BennettChief Commercial Officer